Univariable | Multivariable | |||
---|---|---|---|---|
OR (95 % CI) | p | OR (95 % CI) | p | |
Year | <0.001 | <0.001 | ||
2013 | 1 | 1 | ||
2012 | 2.2 (0.9–5.3) | 0.07 | 2.1 (0.9–5.1) | 0.09 |
2011 | 6.4 (3.0–14) | <0.001 | 6.2 (2.9–13) | <0.001 |
2010 | 3.7 (1.6–8.5) | 0.002 | 3.5 (1.5–8.1) | 0.003 |
Treatment | 0.03 | 0.057 | ||
NNRTI | 1 | 1 | ||
PI | 1.9 (1.2–3.1) | 0.007 | 1.8 (1.1–2.8) | 0.017 |
Other | 1.4 (0.6–3.2) | 0.4 | 1.3 (0.6–3.0) | 0.5 |
Baseline VL (log10 HIV RNA) | 1.4 (1.1–1.8) | 0.007 | 1.4 (1.1–1.8) | 0.005 |
CD4 nadir | 1.0 (1.0–1.0) | 0.14 | ||
Age (years) | 1.0 (0.99–1.02) | 0.6 | ||
Female | 0.8 (0.5–1.4) | 0.5 | ||
HBV | 0.6 (0.1–3.9) | 0.6 | ||
HCV | 1.5 (0.6–3.3) | 0.4 | ||
AIDS | 1.3 (0.7–2.3) | 0.4 | ||
Clinic | 0.8 | |||
Ethnicity | 0.8 | |||
Transmission route | 0.6 |